Logo
x

Search

Subscribe Now

Australia

Incyte Enters into a Supply Agreement with Specialised Therapeutics to Launch Tafasitamab and Pemigatinib in Australia and Other Countries

Incyte Enters into a Supply Agreement with Specialised Therapeutics to Launch Tafasitamab and Pemigatinib in Australia and Other C...

  • October 22, 2021
BioFactura Initiates P-I Study of BFI-751 (biosimilar- ustekinumab) in Australia and New Zealand

BioFactura Initiates P-I Study of BFI-751 (biosimilar- ustekinumab) in Australia and New Zealand

  • May 26, 2021
Glaukos Expands its Partnership with Santen for Preserflo MicroShunt

Glaukos Expands its Partnership with Santen for Preserflo MicroShunt

  • May 19, 2021
Samsung Bioepis Expand its Footprints with the Launch of Hadlima (biosimilar- adalimumab) in Australia and Canada

Samsung Bioepis Expand its Footprints with the Launch of Hadlima (biosimilar- adalimumab) in Australia and Canada

  • March 30, 2021
Cipla Expands its Partnership with Alvotech to Commercialize Biosimilars in Australia and New Zealand

Cipla Expands its Partnership with Alvotech to Commercialize Biosimilars in Australia and New Zealand

  • March 2, 2021
Henlius to Initiate P-III Study of HLX04-O (biosimilar- bevacizumab) in Australia

Henlius to Initiate P-III Study of HLX04-O (biosimilar- bevacizumab) in Australia

  • January 29, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.